All Dr. Martens articles – Page 2
-
Article
Footwear stocks track global markets lower in Q2
In the second quarter of 2022, footwear stocks declined significantly in line with global markets, which suffered their strongest pullback in decades. In the U.S., the S&P 500 index posted its worst performance in the first half of the year since 1970. Global markets were hit by raising inflation, a ...
-
News briefs
Dr. Martens trading in line with its expectations
Dr. Martens said that trading since the start of its fiscal year is in line with its expectations and reiterated its full-year guidance. The company’s fiscal year runs from April 1 to March 31. The British shoemaker previously said that it expected full-year revenue growth reaching a high-teen rate thanks ...
-
Article
How Dr. Martens is handling the refurbished market
With consumers starting to tighten their belts and seek value amid rising prices and inflation, the iconic British shoe and bootmaker Dr. Martens is looking to step into the refurbished product market with a trial repair and resale service. The company has teamed up with online secondhand clothing marketplace Depop, ...
-
Article
Dr. Martens lifts revenue guidance due to price hikes
Dr. Martens raised its sales guidance on the back of price increases that will take effect with the forthcoming autumn-winter collection, while its expectations regarding volume growth remain unchanged. The revised outlook comes after the iconic British brand sold a record number of boots and shoes in the full year ...
-
News briefs
Dr. Martens names a new global creative director
Dr. Martens has appointed Darren McKoy as its new global creative director. McKoy has been in the job since December 2021. He joined Dr. Martens in January 2015 as global category manager for footwear and in October 2017 become global category product director. Prior to the British footwear company, ...
-
Article
Brazilian, Indian footwear stocks outperform in a weak environment
In the first quarter of 2022, the share prices of footwear companies fell sharply, tracking global equity markets lower. But, the Indian and Brazilian companies that we monitor for our stock performance survey outperformed their peers over the period.
-
Article
Inflationary pressures are mounting across the board
Thanks to the collective work of the editorial teams of Shoe Intelligence and its sister publication Sporting Goods Intelligence Europe, we have put together a comprehensive analysis of the impact of inflation on the footwear industry. We tried to cover the economic, industrial, financial and some social aspects of inflation ...
-
Article
Dr. Martens’ wholesale business suffers from Covid impact
Dr. Martens suffered a slowdown in revenue growth in the third quarter compared with the first half of its fiscal year due to a drop in wholesale revenues as the company prioritized e-commerce and its own stores, which offer higher margins. But, news of weak wholesale revenues prompted a significant ...
-
Article
Shoe industry marked by IPOs and takeovers in Q4
The footwear industry witnessed further extraordinary finance transactions during the fourth quarter as companies continue to take advantage of the abundant liquidity injected into the financial system by central banks worldwide to shore up the economy after the Covid-19 outbreak last year. Allbirds, the loss-making California-based producer of Wool Runner ...
-
News briefs
Dr. Martens’ main shareholder sells down its stake
IngreLux, a Luxembourg company owned by funds advised by the investment firm Permira, has sold 65 million ordinary shares in Dr. Martens at a price of 395 pence (€4.73-$5.35) each in a placing, raising gross proceeds of approximately £257 million (€307.7m-$347.8m). The price represents a 6 percent discount from the ...
-
Article
Dr. Martens posts stronger H1 results, but warns about U.S. shipping delays
Dr. Martens posted a 46 percent rise in interim profits, driven by a recovery in store sales as they reopened after Covid lockdowns, but the company warned that shipping delays in its U.S. business would continue into the next fiscal year. Pre-tax profit for the six months to Sept. 30 ...
-
Article
Footwear stocks weaker in Q3 on profit-taking
Overall, the price of footwear stocks dropped in the third quarter of 2021 compared with the previous three months on profit-taking after the sector had enjoyed a strong rebound in the first half of the year with the re-opening of the economy, following the easing of Covid-19-related restrictions and the ...
-
News briefs
Dr. Martens, Suicoke in new collaboration
The British brand Dr. Martens and the Japanese shoemaker Suicoke have reunited to create a new sandal called DM Mura, which incorporates the Lorsan outsole from Dr. Martens and the slip-on “Mura” silhouette from Suicoke. The shoes come in Black Smooth Leather or Black New Vibrance Croco, which includes crocodile ...
-
Article
Dr. Martens warns of shipping delays due to Covid-19
The iconic British shoemaker Dr. Martens reported a big jump in first-quarter revenues, driven by continued growth in online sales and the reopening of stores. Revenues in the three months to June 30 rose by 52 percent year-on-year to £147.3 million (€173m-$205.6m). This was against a Covid-19-impacted comparative ...
-
News briefs
Dr. Martens opens a store in Hamburg
On July 22, Dr. Martens opened its first store in Hamburg on Mönckebergstrasse in Hamburg. The 107 square meter store contains artwork made by the local graffiti artist Anna T-Iron . Mönckebergstrasse is close to the main train station and one of the city’s busiest shopping streets. ...
-
Article
OVS jumps to top of fashion transparency ranking but sector progress ‘too slow’
The Italian retailer OVS jumped to the top spot in the 2021 Fashion Transparency Index published by Fashion Revolution as the global activism movement pushing for greater disclosure in fashion supply chains warned that progress in transparency in the sector generally remains “too slow”. OVS reached 78 percent of the ...
-
Article
Stocks of footwear firms benefit from the re-opening of the economy in Q2
In the second quarter, stocks of footwear companies were generally higher as they benefited from the reopening of the economy, following the easing of Covid-19 restrictions, and a subsequent rebound in the consumption of clothing and shoes. Large U.S. footwear companies, which had already posted strong gains in the first ...
-
Article
E-commerce lifts Dr. Martens’ full-year sales
The British footwear brand Dr. Martens reported a jump in full-year revenue and earnings in its first results as a listed company, driven by solid online sales as it reiterated its medium-term guidance. In the year to March 31, 2021, revenues rose by 15 percent to £773.0 million ...
-
News briefs
Dr. Martens to release a boot redesigned by Rick Owens
Through his company, the American designer Rick Owens has produced a new version of the Dr. Martens 1460 Bex platform boot, whose laces recall other Owens designs. The boot will be released on March 20, at a retail price of £299 (€349-$416), with a second Owens-designed model to ...
-
News briefs
Dr. Martens shareholder exercises over-allotment option
Dr. Martens said that the broker Goldman Sachs International exercised the over-allotment option granted by IngreLux , a Luxembourg company owned by funds advised by the British investment firm Permira , as part of the initial public offering of the British footwear company. With the exercise of the ...
- Previous Page
- Page1
- Page2
- Page3
- Next Page